Search: id:"swepub:oai:gup.ub.gu.se/147306" >
Limited stage I dis...
Limited stage I disease is not necessarily indicative of an excellent prognosis in childhood anaplastic large cell lymphoma.
-
Attarbaschi, Andishe (author)
-
Mann, Georg (author)
-
Rosolen, Angelo (author)
-
show more...
-
Williams, Denise (author)
-
Uyttebroeck, Anne (author)
-
- Marky, Ildiko, 1940 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för pediatrik,Institute of Clinical Sciences, Department of Pediatrics
-
Lamant, Laurence (author)
-
Horibe, Keizo (author)
-
Wrobel, Grazyna (author)
-
Beishuizen, Auke (author)
-
Wössmann, Wilhelm (author)
-
Reiter, Alfred (author)
-
Mauguen, Audrey (author)
-
Le Deley, Marie-Cecile (author)
-
Brugières, Laurence (author)
-
show less...
-
(creator_code:org_t)
- American Society of Hematology, 2011
- 2011
- English.
-
In: Blood. - : American Society of Hematology. - 1528-0020 .- 0006-4971. ; 117:21, s. 5616-9
- Related links:
-
https://gup.ub.gu.se...
-
show more...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- Data on incidence, characteristics, and prognosis in stage I childhood anaplastic large cell lymphoma are scarce. Of 463 patients enrolled in the international ALCL99 trial, 36 (8%) had stage I disease and were treated with a prephase chemotherapy, followed by either 3 chemotherapy courses in case of initial complete resection (6 patients) or otherwise by 6 courses of chemotherapy (30 patients). Disease localization was to the peripheral lymph nodes in 26, soft tissue mass in 8, and solitary bone and bronchial disease in 1 patient each. Of the 6 patients with complete resection, none experienced relapse, whereas of the 30 remaining stage I patients, 9 (30%) relapsed, including in all cases a new site of disease involvement and including 3 of 5 anaplastic lymphoma kinase-negative patients. In summary, the failure rate for incompletely resected stage I disease was similar to that for patients with stage II and stage III/IV disease. Whether anaplastic lymphoma kinase negativity contributed to this moderate outcome has to be proven prospectively. This study was registered at www.clinicaltrials.gov as NCT00006455.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Keyword
- Antineoplastic Combined Chemotherapy Protocols
- therapeutic use
- Child
- Female
- Humans
- International Agencies
- Lymphoma
- Large-Cell
- Anaplastic
- drug therapy
- mortality
- pathology
- Male
- Neoplasm Staging
- Prognosis
- Prospective Studies
- Survival Rate
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
-
Blood
(Search for host publication in LIBRIS)
To the university's database
- By the author/editor
-
Attarbaschi, And ...
-
Mann, Georg
-
Rosolen, Angelo
-
Williams, Denise
-
Uyttebroeck, Ann ...
-
Marky, Ildiko, 1 ...
-
show more...
-
Lamant, Laurence
-
Horibe, Keizo
-
Wrobel, Grazyna
-
Beishuizen, Auke
-
Wössmann, Wilhel ...
-
Reiter, Alfred
-
Mauguen, Audrey
-
Le Deley, Marie- ...
-
Brugières, Laure ...
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Cancer and Oncol ...
- Articles in the publication
-
Blood
- By the university
-
University of Gothenburg